Robert G. Feldman, M.D.
|Neurology||Boston University School of Medicine, Boston, MA|
Area:Neurotoxicology, Parkinson's disease
Google:"Robert G. Feldman, M.D., chairman, Neurology, Boston University School of Medicine"
Mean distance: 16.81 (cluster 11)
Cross-listing: Neuropathology Tree
ParentsSign in to add mentor
ChildrenSign in to add trainee
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Ratner MH, Farb DH, Ozer J, et al. (2014) Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides. Interdisciplinary Toxicology. 7: 123-33|
|Hauser RA, Lew MF, Hurtig HI, et al. (2009) Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 564-73|
|Biglan KM, Schwid S, Eberly S, et al. (2006) Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23|
|Karamohamed S, Golbe LI, Mark MH, et al. (2005) Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91|
|Ellis T, de Goede CJ, Feldman RG, et al. (2005) Efficacy of a physical therapy program in patients with Parkinson's disease: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation. 86: 626-32|
|Karamohamed S, DeStefano AL, Wilk JB, et al. (2003) A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61|
|Miller JW, Selhub J, Nadeau MR, et al. (2003) Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology. 60: 1125-9|
|Feldman RG. (2003) Neurotoxic Manifestations of Exposure to Metals Office Practice of Neurology: Second Edition. 1287-1293|
|Wiesman JF, Feldman RG. (2003) Drug-Induced Peripheral Neuropathies Office Practice of Neurology: Second Edition. 626-633|
|Siderowf A, Stern M, Shoulson I, et al. (2002) A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943|